Tag: PARP inhibitors

Categories
more
Tags
patient journeycoronovirusTarget Groupsbreast cancerHealthcare market researchprecision medicineMedTech & Diagnostics IndustriesMarket InnovationCompetitive IntelligenceNSCLCOncologyQuantitative Market Research

more
Current Posts
EU COVID-19 report cover
30.07.2020
Psyma Releases EU Survey Results on ...
US COVID-19 Impact Report
23.06.2020
Psyma Releases US Survey Results on ...
09.04.2020
It's Not Business As Usual
 more
Authors
Jeff Judek
Chief Executive Officer,
Psyma International Inc.
Jill Salisbury
Vice President,
Psyma International Inc.
James Roberts
Vice President,
Psyma International Inc.
 more
Stay informed
Contact
Corporate Headquarters
Rückersdorf bei Nürnberg>
PSYMA GROUP AG
Fliedersteig 15 - 17
90607 Rückersdorf / Nürnberg
Germany
CONTACT REQUEST
SHOW LOCATIONS
Imprint | Privacy policy
copyright © 2023 PSYMA GROUP AG